Brito, Luis A.
Moderna Therapeutics,
United States
2025 Rank: 180330
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Virology
Rank in SubField 1: 1359 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 180330 | 205023 |
| Total Cites | 742 | 758 |
| H-index | 13 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 100 | 100 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 373 | 377 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 576 | 586 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.29 |
| Self-Citation Percentage |
2.11%
|
|
Brito, Luis A.
Moderna Therapeutics,
United States
2024 Rank: 196082
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 982 out of 71672 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 196082 | 223783 |
| Total Cites | 642 | 667 |
| H-index | 13 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 88 | 90 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 283 | 295 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 474 | 492 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.36 |
| Self-Citation Percentage |
3.75%
|
|
Brito, Luis A.
Moderna Therapeutics,
United States
2023 Rank: 162507
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 952 out of 68279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 162507 | 186071 |
| Total Cites | 757 | 793 |
| H-index | 15 | 15 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 123 | 128 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 340 | 348 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 484 | 494 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.61 |
| Self-Citation Percentage |
4.54%
|
|
Brito, Luis A.
Moderna Therapeutics,
United States
2022 Rank: 157604
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1101 out of 65731 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157604 | 180322 |
| Total Cites | 611 | 651 |
| H-index | 15 | 15 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 117 | 121 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 240 | 252 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 386 | 397 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.64 |
| Self-Citation Percentage |
6.14%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.